The aim of the study was to analyse the information needs of the Clinical Trials Unit (CTU) at Velindre Hospital, a specialist cancer centre, and the Wales Cancer Trials Network (WCTN). The purpose was to determine the trial information needs that may be collected via the Velindre hospital information system, and the data structure required to store that information. A case study approach was adopted with semi-structured interviews (17 face-to-face interviews with staff based at Velindre Hospital and three telephone interviews with staff at other trial centres in Wales) complemented by document analysis, and an analysis of trial activity databases either in use or under development. A core information set, common to all trials, was identified and this can be collected in ISCO. The document-based trial-specific information is best made available in HTML format. Entity-relationship model diagrams were developed to show the data structure. The study concluded that trial activity information needs can be satisfied as a byproduct of collecting patient trial information in a hospital information system. Patient care should be improved by the greater availability of trials information, and accrual may be increased through identification of potential trial candidates.
Introduction
The Wales Cancer Trials Network (WCTN) supports cancer clinical trials in Wales, some of which are conducted at the Clinical Trials Unit (CTU) at Velindre Hospital in Cardiff. The CTU prepares and co-ordinates trials at Velindre and its peripheral clinics, and the work includes preparation and co-ordination of ethical submissions to the multicentre ethics committees and the local ethics committees. The WCTN, which was established in 1998, identified a need for a database that would track patient accrual to trials across Wales, to provide reporting of figures to NHS Trust Boards. As the WCTN co-ordinating office is based at Velindre, and the hospital information system (ISCO) (Information System for Clinical Organizations) could easily be rolled out all over Wales, an obvious solution to the tracking problem was an extension to the original hospital information system (ISCO). Additionally, ISCO is already used by the research nurses at Velindre for retrieving information about patients. This paper describes the information needs analysis conducted for both WCTN and the CTU, to determine in detail the information required for running trials, and whether that information could be made available from within the hospital information system. The work involved data analysis and modelling, with development of prototype data capture screens for trials information in ISCO.
Background
Clinical trials are highly regulated. Many countries have worked towards the international harmonization of practice guidelines, which resulted in the 1996 agreement (International Conference on the Harmonization of Technical Requirements, ICH Harmonized Tripartite Guidelines for Good Clinical Practice). More locally, the ABPI (Association of the British Pharmaceutical Industry) issues guidance on good clinical practice. Some trials would be impossible without multicentre co-operation and it is rare that an adequate number of patients can be recruited by a single institution to conduct a phase III clinical trial (trials that establish the efficacy of a drug compared to standard treatment or placebo, using in most instances a randomized controlled trial) [1] , particularly when the disease is of low incidence [2] . Multicentre trials benefit from the study of a more diverse population [3] , as well as a wider knowledge base as more clinicians are involved. There are logistical disadvantages, as there is the need in the UK to apply to many local ethics committees for approval [4] [5], extra resources are required to keep the trial database updated [6] , or deal with other co-ordination activities, particularly when there are different languages and cultures involved [7] .
The WCTN deals with strategic all-Wales issues such as the adoption of trials by the all-Wales cancer care multidisciplinary teams (MDTs) [8] , trials education and research management. At the time of the needs analysis, WCTN was managing three trials with around 25 nurses involved, and 350-400 patients entering these trials per annum. As WCTN is publicly funded it runs publicly funded trials. The CTU at Velindre was founded in 1994, delivering trial management at Velindre. It is funded by a variety of sources and studies done locally are usually phase III, but they may also be phase II or less often phase I studies (phase I trials find the maximum tolerated dose, phase II trials find the optimum safe dose).
Methods
A case study approach was used for the information needs analysis part of the project, as this was deemed appropriate for the 'why and how' questions [9] . Information systems research frequently uses a case study approach as a qualitative method and the case study approach may be the most appropriate method of studying information systems development and use within organizations [10] . The drawbacks, such as the difficulty of generalizing findings, the subjectivity and the volume of data that might be collected, can be reduced through triangulation, using different methods of corroboration, and using a chain of evidence to show how conclusions were drawn, as well as being as honest as possible about assumptions made. The research in this case was done by a member of the information department at Velindre, and the subjectivity of someone who operates ISCO on a daily basis must be acknowledged. The advantages of 'insider knowledge' must be accepted too, and the problem of access to interviewees was greatly decreased as a result of the position held within the organization.
The methods comprised:
• literature review, to set the context of clinical trials work in Wales within a larger context
• definition of the scope of the analysis (CTU, WCTN co-ordinating office and the WCTN supported centres)
• data collection via surveys (telephone and face-to-face interviews), document analysis.
Interviews
Semistructured interviews were selected as the main method of data collection, in view of the newness of the organizations concerned and the likely changes in information needs in the future. The interview questions were based around overview task analysis, which assumes that information requirements are determined by the tasks performed [11] . The rationale for using this approach was the need to identify the information required to perform tasks, and assess whether that information was available. Pilot interviews were conducted with two CTU research nurses, and amendments made to the order of the questions and number of questions asked. Pilot interviews also revealed that much of the information exchanged is fairly informal and that it would be necessary to include minutes of interdepartmental meetings in the data analysis. Another lesson learnt from the pilot was that staff occasionally found recall of specific data items difficult, as each trial may require information unique to that trial. Document analysis was therefore done prior to the main interviews, in order that specific queries could be addressed during interviews, rather than following these up at a later date.
Face-to-face interviews (n = 17) were possible with staff based at Velindre, and staff (n = 3) at centres outside Cardiff were interviewed by telephone. All interviews were recorded by means of handwritten notes and typed up immediately afterwards. As much of the interview involved factual information there was no good reason for tape recording and transcribing. The interview notes were verified with the interviewees, and amendments made accordingly.
The sample included representatives from different user groups, including all disciplines
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involved to ensure knowledge triangulation, as well as all locations for location triangulation [12] .
Document analysis
All Access databases in use in WCTN and CTU were analysed for content. Report forms, trials forms and meeting minutes were similarly analysed to examine the purpose and intent of the document, the required data items, their use and format.
Data analysis
Content analysis of the verified interview notes revealed the information needs, the desired data items, existing information problems and the functions users would like in ISCO. A soft systems approach [13] was used as this made it easier to verify the interpretation of the data, and the identified information flows, with users. The development of an entity-relationship model and a data dictionary proceeded alongside the soft systems analysis.
Results
The details derived about the trials process are presented first, followed by discussion of the identified information gaps and problems, and the ways in which the hospital information system could be extended to solve those problems.
The trials process
A protocol documents the clinical trial procedures and is a quality control tool [14] , usually written by pharmaceutical companies or the clinical co-ordinator of the study. Data collection forms (case report forms or CRFs) are usually designed alongside the protocol and refined as necessary. Various forms are required to collect demographic information, investigations, treatments and other trial specific items [15] . Protocols do not follow a prescribed layout but are likely to contain:
• aims and objectives of the trial
• its background and rationale
• inclusion and exclusion criteria for patients
• type of participants
• design type (phase, and whether randomized or not)
• drug and method of administration
• adverse events
• data collection methods and data collection forms
• quality control of data
• analysis methods
• declaration of Helsinki compliance for research ethics
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• information to be provided to the patient and how the trial will be explained
• patient consent (verbal/written) and consent form.
Matching the services of a clinical trials unit and a trial co-ordinating body can be done in a variety of ways. Trials may be adopted by the all-Wales MDTs, or from within the CTU, by clinicians, or through requests from pharmaceutical companies. Trials need to be costed, as the cost of enrolling a patient in a trial may be higher than the cost of standard treatment [16] . Costs arise from research (data collection and monitoring), service support (e.g. extra blood tests for a trial) and excess treatment (high-cost trial drugs or other treatment).
Once a trial has received ethical approval from the appropriate committees, WCTN registers the trial on the National Research Register, as there are no local Research and Development offices. Trials registers have a number of benefits [17] , including more effective co-ordination of research (thus avoiding duplication of effort) and increased patient recruitment [18] . Most recruitment at Velindre is achieved through screening of patient casenotes against the trial eligibility criteria before a clinic is held. Pharmacy staff are involved if trial recruitment depends on previous treatment history, contained in the pharmacy database. The pharmacy dispenses and checks all trial treatments.
Eligibility criteria are trial specific but usually include:
• age
• diagnosis, histologically confirmed
• examination, investigations and medical history
• allergies/toxicities
• life expectancy
• ability of the patient to comply with study requirements (and ability to give consent)
• willingness of patient to participate
• performance status (measure of health status).
At Velindre, a label or handwritten note is put in the inside cover of the patient casenote to signify that the patient is on a trial, together with the date of randomization/registration, the start date of treatment, and appointments booked. The research nurse is responsible for checking that the trial protocol is followed by all departments involved. Casenotes for trial patients are kept in the CTU for CRF completion, and this requires good liaison with the medical records department. The most detailed information is collected at the beginning and end of the study, at the first and last visit. Follow-up data has to be collected even after a patient has withdrawn from a trial. CRFs are used to record -for example -serious adverse and adverse events and tumour measurements.
Trial activity is monitored by the CTU to check on the rate of accrual, as trials may have to be closed earlier than expected, or stopped altogether if, for example, the treatment is excessively better than the standard, or the side effects or toxicity too severe to continue. Pharmaceutical company monitors visit trials departments regularly, taking copies of CRFs, and (at CTU) liaising with research nurses. When the data collection is complete, and all data queries complete, the trial may be signed off, and the documentation retained by the pharmaceutical company monitor, or the NHS Hospital Trust for 15 years.
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Identified information gaps and problems
Problems identified by interviewees were concerned with gaining access to information when and where required, the quality of information available, and general problems in dealing with IT and the volume of information to be processed. Access problems included:
• obtaining investigation results
• casenote tracking including archived casenotes and notes from other hospitals
• obtaining tumour measurements
• availability of information sheets and use on the wards
• data collection for longstanding trials
• access to appropriate information out of hours (e.g. when the CTU is closed) and knowing which trial nurse to contact.
Problems with specific information items included:
• obtaining specific trial information for audit, including the identification of trial patients
• insufficient chemotherapy information available in ISCO for CRF completion
• for non-trials staff, knowing whether a patient is on a trial or not.
More general problems concerned:
• manual collection of trial activity data and the paperwork involved
• amount of trial publications to be read and appraised
• need for more data collection in ISCO
• IT confidence and competence.
At present ISCO is used to:
• check on patient status, including those who did not attend last appointment, as well as outcome, progression, survival
• check on patient's source of referral
• check patient appointments
• review clinic annotations and demographic details
• review medical history
• track casenotes, print patient labels, duplicate casenotes
Development of rich pictures (soft systems analysis)
Three rich pictures [12] were developed, two showing the selection and approval process for trials in the WCTN and CTU respectively. The third picture (Figure 1) shows the level of co-operation required between departments for the smooth running of a trial, and the pivotal role of the research nurse [19] [20], as demonstrated by a summary 'CATWOE' analysis derived from the rich picture (Table 1 ). 
Comparison of options
Possible methods of collecting trial data for WCTN and CTU were to continue with the current system, using a new stand-alone database or ISCO. The main problem with the current system was the inefficiency of the procedures, entering data into several standalone databases, and the lack of access to the data for the satellite sites once the information was passed to WCTN. There was no easy, or standard method of informing all staff that a patient was on a trial, which means that the protocol may not be followed in full. A stand-alone database had several advantages, including the ease of tailoring this to specific WCTN/CTU needs, and there are several dedicated trials database packages available [21] . The main disadvantages concern costs (including ongoing support costs), the need to re-enter all the patient data, and possible problems in enabling multisite access. ISCO had the advantage of allowing multisite access from any NHS site in Wales, some patient information was already available, and making further amendments, such as flagging trial patients, could be done easily. In addition, ISCO uses NHS standardized
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118 data, user support is available and procedures such as flagging potentially eligible patients would not be difficult to implement. Quality criteria were met most cost-effectively by expanding the existing ISCO system.
Possible ISCO development
Most of the problems and gaps that users identified could be addressed by ISCO and other problems (lack of IT knowledge) are general organizational problems (Table 2 , example extract from full list). Retrospective data entry of data from old trials was not deemed economic. What was gratifying was that the user 'wish list' for features such as those listed below would automatically be resolved if the solutions (examples listed in Table 2 ) were implemented: • ability to add trial follow-up information (nursing notes)
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• structured outcome information
• extraction of trial documents from ISCO
• alert set when trial patient admitted on a ward
• improved chemotherapy information (for CRF completion).
Using the lists of identified user problems, user wish-list items and trials information collected in existing systems a list of around 60 possible data collection items (with noted purpose) was developed (Table 3 provides an example extract).
Trial information
Trial documentation is word processed and can be saved as an HTML document which enables it to be published on the Internet or on HOWIS (Health of Wales Information Service: the NHS Wales intranet), or made available within ISCO in HTML format. Pharmaceutical company confidentiality rules demand appropriate security permissions so that information is only made available to staff on a 'need to know' basis.
Development of ERM model for data structure
The entity-relationship model (ERM) for clinical trials was developed on the basis of the information collected from the interviews and the document analysis. The ERM shows that a patient may be in more than one trial over time (though rarely simultaneously), and 'Trial-Patient' is an intersection entity to denote the recording of trial specific information for a particular patient (Figure 2 ).
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120 A data dictionary of items for inclusion in ISCO was developed (example in Table 4 ). The information collected for trials can be divided into two types, patient-specific data and trial-specific data. Trial data can be divided into trial documentation and data required for trial management, with the former best stored as HTML and the latter within ISCO.
User requirements were then prioritized for inclusion into ISCO, according to complexity of work involved and the urgency of the work. Some, such as 'trial nurse patient visit notes' could be based on existing modules (an existing palliative care module in this instance). Others, such as randomisation, which is usually dealt with by outside organizations or WCTN will be considered later. Ad hoc reporting was planned for the immediate future as data warehouse prototypes were under development.
The ERM was modified to illustrate the reports required, required data items and to reflect the current ISCO structure. A new table Trial-Provider was required for the study centre specific trial information. The hcor (healthcare organization) hcpo (healthcare professional-organization link table) and hcpi (healthcare professional) tables were originally created in ISCO to hold addresses and coding information for healthcare professionals and organizations. A more detailed data dictionary was collated, taking account of ISCO standards, the NHS Data Dictionary, the Welsh NHS Data Dictionary and the revised ERM ( Figure 3 ).
Implementation and evaluation
Implementation and evaluation plans included:
• design of prototype data entry screens
• obtaining user approval for screens
• creation of tables within ISCO
• creation of HTML versions of trial documentation
• programming of data entry and trial documentation retrieval
• user acceptance testing
• user training
• post-implementation evaluation, including benefits analysis.
The rich pictures developed during the analysis are to be used on the WCTN Website to give members of the public an overview of the trials process.
Benefits
Benefits largely concern the quality and availability of information within ISCO. All ISCO users are now aware if a patient is on a trial, research nurses can record their notes directly 
Limitations for ISCO
Patient information required for trials may need to be in a highly structured format (e.g. for chemotherapy and toxicity data). More work is required on this problem in view of the medical input, data entry requirements and a lack of standardized coding systems for trials data. Extra staff and secretarial support may be required for trial data entry such as the nursing annotations. 
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Discussion
The original aim of the research was to determine the trial information needs that may be collected in ISCO. An in-depth, soft systems approach was taken, which provided a depth of detail that might not have been provided otherwise. The concomitant danger is that user expectations are raised, only to be dashed if plans do not proceed as quickly as hoped. Information needs of a clinical trials unit were found to be more wide-ranging than originally envisaged at the start of the project. Data collection requirements are onerous because of the need to meet strict regulatory requirements. Commercial trials require a greater level of detail. Some of the information required about the trials, particularly the trial activity information, can be collected as a byproduct of collecting patient information but some additional information has had to be entered into ISCO to cope with trial needs. Most of the patient information is already collected, but more work is required to meet the detail necessary for toxicity and chemotherapy data, and standardization of coding systems will be necessary. ISCO's potential for increasing accrual to trials is important, as accrual is often difficult, requiring good prompting and a good matching process [22] .
Generalizing the results of this study to other clinical trials units is difficult, as some trials units are not situated within a specialist hospital as is CTU, and some manage data collection for all centres participating in multicentre trials, with the associated need for databases to manage administrative data for clinical trials [23] . The American Medical Informatics Association (AMIA) has a Clinical Trials Information Systems Working Group, with the focus of its work a framework for Clinical Trials Information Systems. Such a framework might incorporate other software packages [24] , and in the future more emphasis may be placed on use of the Internet for trial monitoring, with electronic CRFs [25] as part of the evolution of electronic medical records [26] . Cancer treatment in the UK is targeted for improvement as cancer outcomes in the UK are poor compared to those obtained in other countries, and the aim of the Calman-Hine report [27] was a better structure for cancer services, with the necessary entry of patients into trials [28] the responsibility of the entire network of cancer units and cancer centres.
Conclusions
The findings of this research confirmed that some information required by the clinical trials unit could be supplied from the hospital information system. The detailed soft systems analysis provided a clearer picture of the problems and priorities of the staff. Implementation of the plans outlined in the paper is under way. Entry of basic trial information into ISCO (title, acronym, treatment arms, data approved by ethics committee etc.) as well as basic patient trial information (e.g. date registered/randomized, study number, reason for not enrolling, reason for withdrawal) is at the development stage. Casenote tracking has been implemented, and is in use across several departments at Velindre, and flagging of trial patients scheduled for implementation by April 2002. The Cancer Information Framework (CIF) for Wales datasets require that all hospitals record whether a patient has been offered a trial and the outcome of that offer. WCTN has secured extra funding from the National Assembly for Wales and the Cancer Research Campaign, and the funding will support eight research teams across Wales.
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